Hyper IgM syndrome

An overview of Hyper IgM syndrome, a rare immunodeficiency disorder

Hyper IgM syndrome is a group of rare primary immunodeficiency disorders characterized by a defect in the ability of B cells to undergo class switch recombination, resulting in normal or elevated levels of immunoglobulin M (IgM) and decreased levels of other immunoglobulin isotypes such as IgG, IgA, and IgE. This condition leads to increased susceptibility to infections and other immune-related complications.

Pathophysiology

Hyper IgM syndrome is caused by genetic mutations that affect the interaction between T cells and B cells, which is crucial for the process of class switch recombination. The most common form of Hyper IgM syndrome is X-linked Hyper IgM syndrome, caused by mutations in the CD40 ligand (CD40L) gene located on the X chromosome. Other forms can be autosomal recessive, involving mutations in genes such as AID (activation-induced cytidine deaminase) or UNG (uracil-DNA glycosylase).

Clinical Features

Patients with Hyper IgM syndrome typically present with recurrent bacterial infections, particularly of the respiratory tract, due to the lack of IgG. They may also experience opportunistic infections, such as those caused by Pneumocystis jirovecii, a fungus that can lead to severe pneumonia.

Pneumocystis jirovecii pneumonia is a common opportunistic infection in patients with Hyper IgM syndrome.

Other clinical features may include autoimmune disorders, neutropenia, and an increased risk of developing certain malignancies.

Diagnosis

The diagnosis of Hyper IgM syndrome is based on clinical evaluation, immunological studies, and genetic testing. Laboratory findings typically show normal or elevated levels of IgM with low levels of IgG, IgA, and IgE. Genetic testing can confirm mutations in the genes associated with the syndrome.

Management

Management of Hyper IgM syndrome involves regular immunoglobulin replacement therapy to provide the missing antibodies and prevent infections. Prophylactic antibiotics may be used to prevent opportunistic infections such as Pneumocystis jirovecii pneumonia. In some cases, hematopoietic stem cell transplantation may be considered as a curative treatment.

Prognosis

The prognosis for individuals with Hyper IgM syndrome varies depending on the specific genetic mutation and the effectiveness of treatment. Early diagnosis and appropriate management can improve outcomes and quality of life for affected individuals.

Related pages

• Primary immunodeficiency
• B cell
• T cell
• Immunoglobulin
• Pneumocystis jirovecii